Prevest Denpro (BOM:543363) EBIT: ₹276.1 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543363 Prevest Denpro Ltd BOM:543363
84 GF Score
Price ₹390.00
GF Value ₹622.13
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Prevest Denpro EBIT?

Prevest Denpro BOM:543363 +0.78% 84 EBIT is ₹276.1 Mil as of Mar. 2026. GuruFocus rates BOM:543363 with a GF Score™ of 84/100 and a GF Value™ of ₹622.13 (Possible Value Trap). The stock has 3 warning signs investors should review.

Prevest Denpro's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹78.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹276.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Prevest Denpro's annualized ROC % for the quarter that ended in Mar. 2026 was 38.84%. Prevest Denpro's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 73.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Prevest Denpro's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.14%.


Prevest Denpro  (BOM:543363) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Prevest Denpro's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=256.156 * ( 1 - 25.46% )/( (0 + 491.551)/ 1 )
=190.9386824/491.551
=38.84 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1331.907 - 24.914 - ( 815.442 - max(0, 71.414 - 1064.915+815.442))
=491.551

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Prevest Denpro's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=312.4/( ( (0 + max(0, 0)) + (266.005 + max(157.676, 0)) )/ 1 )
=312.4/( ( 0 + 423.681 )/ 1 )
=312.4/423.681
=73.73 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(87.117 + 108.939 + 33.034) - (24.914 + 0 + 46.5)
=157.676

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Prevest Denpro's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=276.124/3865.728
=7.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prevest Denpro EBIT Related Terms


Prevest Denpro EBIT Historical Data

* Premium members only.

The historical data trend for Prevest Denpro's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prevest Denpro EBIT Chart

Prevest Denpro Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 161.56 209.57 214.32 242.50 276.12

Prevest Denpro Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.51 59.88 73.72 64.42 78.10

BOM:543363 vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Prevest Denpro's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prevest Denpro EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prevest Denpro's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Prevest Denpro's EV-to-EBIT falls into.


BOM:543363
84GF Score
Prevest Denpro Ltd BOM:543363
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prevest Denpro EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹276.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹276.1 Mil mean?
Prevest Denpro (BOM:543363) has a EBIT of ₹276.1 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Prevest Denpro.
Is Prevest Denpro's EBIT too high?
Prevest Denpro's current EBIT is ₹276.1 Mil. Overall, Prevest Denpro has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's EBIT compare to ISRG and BDX?
Prevest Denpro's EBIT of ₹276.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Prevest Denpro. Prevest Denpro's current EBIT is ₹276.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹622.13, compared to a current price of ₹390.00 — trading 37.3% below its estimated fair value. The current EBIT is ₹276.1 Mil. Prevest Denpro's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current EBIT is ₹276.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prevest Denpro (BOM:543363) Overvalued in 2026?

Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued. The current stock price of ₹390.00 is trading 37.3% below its estimated GF Value™ of ₹622.13. GuruFocus considers Prevest Denpro to be Possible Value Trap.

Key valuation signals for BOM:543363:

  • EBIT: ₹276.1 Mil
  • GF Value™: ₹622.13 vs. price of ₹390.00 (37.3% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Prevest Denpro Business Description

Address EPIP, Kartholi, Bari Brahmana, Samba, Jammu & Kashmir, HP, IND, 181133
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
84GF Score

Get the complete analysis for BOM:543363

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹390.00
Price
₹622.13
GF Value